These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16996113)

  • 1. Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma.
    Arimoto T; Nakagawa S; Yasugi T; Yoshikawa H; Kawana K; Yano T; Taketani Y
    Gynecol Oncol; 2007 Jan; 104(1):32-5. PubMed ID: 16996113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of paclitaxel and carboplatin in patients with endometrial cancer].
    Nakamura T; Onishi Y; Yamamoto F; Kouno S; Maeda Y; Hatae M
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):257-62. PubMed ID: 10700897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
    Pectasides D; Xiros N; Papaxoinis G; Pectasides E; Sykiotis C; Koumarianou A; Psyrri A; Gaglia A; Kassanos D; Gouveris P; Panayiotidis J; Fountzilas G; Economopoulos T
    Gynecol Oncol; 2008 May; 109(2):250-4. PubMed ID: 18299146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
    Papadimitriou CA; Bafaloukos D; Bozas G; Kalofonos H; Kosmidis P; Aravantinos G; Fountzilas G; Dimopoulos MA;
    Gynecol Oncol; 2008 Jul; 110(1):87-92. PubMed ID: 18455782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
    Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP
    Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S
    Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
    Papadimitriou CA; Fountzilas G; Bafaloukos D; Bozas G; Kalofonos H; Pectasides D; Aravantinos G; Bamias A; Dimopoulos MA;
    Gynecol Oncol; 2008 Oct; 111(1):27-34. PubMed ID: 18644619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
    Scudder SA; Liu PY; Wilczynski SP; Smith HO; Jiang C; Hallum AV; Smith GB; Hannigan EV; Markman M; Alberts DS;
    Gynecol Oncol; 2005 Mar; 96(3):610-5. PubMed ID: 15721401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer.
    Akram T; Maseelall P; Fanning J
    Am J Obstet Gynecol; 2005 May; 192(5):1365-7. PubMed ID: 15902110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
    Lupe K; Kwon J; D'Souza D; Gawlik C; Stitt L; Whiston F; Nascu P; Wong E; Carey MS
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):110-6. PubMed ID: 17084542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus.
    Toyoshima M; Akahira J; Matsunaga G; Niikura H; Ito K; Yaegashi N; Tase T
    Gynecol Oncol; 2004 Sep; 94(3):774-8. PubMed ID: 15350372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.
    Pectasides D; Pectasides E; Papaxoinis G; Xiros N; Sykiotis C; Papachristodoulou A; Tountas N; Panayiotides J; Economopoulos T
    Gynecol Oncol; 2008 Sep; 110(3):299-303. PubMed ID: 18602677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study.
    Dimopoulos MA; Papadimitriou CA; Georgoulias V; Moulopoulos LA; Aravantinos G; Gika D; Karpathios S; Stamatelopoulos S
    Gynecol Oncol; 2000 Jul; 78(1):52-7. PubMed ID: 10873410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
    Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
    Pignata S; Scambia G; Pisano C; Breda E; Di Maio M; Greggi S; Ferrandina G; Lorusso D; Zagonel V; Febbraro A; Riva N; De Rosa V; Gallo C; Perrone F;
    Br J Cancer; 2007 Jun; 96(11):1639-43. PubMed ID: 17486128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV; Bhagat K; Swenerton KD; Hoskins PJ
    Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy with paclitaxel and carboplatin (TC therapy) for endometrial cancer].
    Misawa A; Nagao M; Kushimoto T; Yasuda M
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1901-5. PubMed ID: 19011339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
    Shibata K; Kikkawa F; Kondo C; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
    Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.